Malignant T Cell Amplified Sequence 1 (MCTS1) Peptid
MCTS1
Reaktivität: Human
Wirt: Synthetic
BP, BI
Produktnummer ABIN5686981
Kurzübersicht für Malignant T Cell Amplified Sequence 1 (MCTS1) Peptid (ABIN5686981)
Target
MCTS1
(Malignant T Cell Amplified Sequence 1 (MCTS1))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), BioImaging (BI)
-
-
Produktmerkmale
- MCTS1 peptide corresponds to 15 amino acids of MCTS1.
-
-
-
-
Applikationshinweise
- MCTS1 peptide is used for blocking the activity of MCTS1 antibody . The MCTS1 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- MCTS1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
- MCTS1 (Malignant T Cell Amplified Sequence 1 (MCTS1))
-
Gen-ID
- 28985
-
NCBI Accession
- NP_054779, NP_001131026
-
OMIM
- 74735052
-
UniProt
- Q9ULC4
Target
-
Sie sind hier:
